1 The Department of Pediatrics, the Johns Hopkins University, and the Harriet Lane Home, the Johns Hopkins Hospital, Baltimore.
Seven patients with congenital familial nonhemolytic jaundice with kernicterus are presented. Six of these were hospitalized and studied. One was diagnosed by history. The abnormality appears to be genetically determined, being inherited most likely as a lethal recessive characteristic. The only abnormal laboratory findings are pronounced elevation of indirect serum bilirubin and delayed excretion of injected bilirubin. Pathologically, bile thrombi in the canaliculi were found in all patients studied, with very slight periportal fibrosis present in the liver sections from Cases 1, 5 and 6. In the single brain examined, Case 2, kernicterus was described. The prognosis is extremely poor, the patients generally dying in the first year of life. No therapeutic measures have been found helpful. The similarity to a previously described disease, familial nonhemolytic jaundice, is discussed.
Submitted on March 22, 1952
This article has been cited by other articles:
![]() |
N. Nguyen, J. A. Bonzo, S. Chen, S. Chouinard, M. J. Kelner, G. Hardiman, A. Belanger, and R. H. Tukey Disruption of the Ugt1 Locus in Mice Resembles Human Crigler-Najjar Type I Disease J. Biol. Chem., March 21, 2008; 283(12): 7901 - 7911. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. McDonagh Bilirubin Toxicity to Human Erythrocytes: A More Sanguine View Pediatrics, July 1, 2007; 120(1): 175 - 178. [Full Text] [PDF] |
||||
![]() |
J. F. Watchko Vigintiphobia Revisited Pediatrics, June 1, 2005; 115(6): 1747 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Brown Kernicterus: Past, Present, and Future NeoReviews, February 1, 2003; 4(2): e33 - 40. [Full Text] [PDF] |
||||
![]() |
S. S. Ghosh, B. S. Sappal, G. V. Kalpana, S. W. Lee, J. R. Chowdhury, and N. R. Chowdhury Homodimerization of Human Bilirubin-Uridine-diphosphoglucuronate Glucuronosyltransferase-1 (UGT1A1) and Its Functional Implications J. Biol. Chem., November 2, 2001; 276(45): 42108 - 42115. [Abstract] [Full Text] [PDF] |
||||
![]() |
W S Lee, P J McKiernan, S V Beath, M A Preece, D Baty, D A Kelly, B Burchell, and D J Clarke Bile bilirubin pigment analysis in disorders of bilirubin metabolism in early infancy Arch. Dis. Child., July 1, 2001; 85(1): 38 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. KADAKOL, B. S SAPPAL, S. S GHOSH, M. LOWENHEIM, A. CHOWDHURY, S. CHOWDHURY, A. SANTRA, I. M ARIAS, J. R. CHOWDHURY, and N. R. CHOWDHURY Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus J. Med. Genet., April 1, 2001; 38(4): 244 - 249. [Full Text] |
||||
![]() |
J. F. Lucey, G. K. Suresh, and A. Kappas Crigler-Najjar Syndrome, 1952-2000: Learning From Parents and Patients About a Very Rare Disease and Using the Internet to Recruit Patients for Studies Pediatrics, May 1, 2000; 105(5): 1152 - 1154. [Full Text] |
||||
![]() |
R. F. Labbe, H. J. Vreman, and D. K. Stevenson Zinc Protoporphyrin: A Metabolite with a Mission Clin. Chem., December 1, 1999; 45(12): 2060 - 2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Kren, B. Parashar, P. Bandyopadhyay, N. R. Chowdhury, J. R. Chowdhury, and C. J. Steer Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type I with a chimeric oligonucleotide PNAS, August 31, 1999; 96(18): 10349 - 10354. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Pearson The Ever-changing Content of Pediatrics Over Fifty Years Pediatrics, July 1, 1998; 102(1): 168 - 176. [Full Text] |
||||
![]() |
I. J. Fox, J. R. Chowdhury, S. S. Kaufman, T. C. Goertzen, N. R. Chowdhury, P. I. Warkentin, K. Dorko, B. V. Sauter, and S. C. Strom Treatment of the Crigler-Najjar Syndrome Type I with Hepatocyte Transplantation N. Engl. J. Med., May 14, 1998; 338(20): 1422 - 1427. [Full Text] [PDF] |
||||
![]() |
G. Suresh and J. F. Lucey Lack of Deafness in Crigler-Najjar Syndrome Type 1: A Patient Survey Pediatrics, November 1, 1997; 100(5): e9 - e9. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ilan, G. Droguett, N. R. Chowdhury, Y. Li, K. Sengupta, N. R. Thummala, A. Davidson, J. R. Chowdhury, and M. S. Horwitz Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression PNAS, March 18, 1997; 94(6): 2587 - 2592. [Abstract] [Full Text] [PDF] |
||||